RXL Fees and Costs — ProShares Ultra Health Care
Data updated: 2026-08-14
The net expense ratio is 0.95%: a 0.75% management fee plus 0.30% other expenses, less a 0.10% fee waiver. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $861 in broker commissions, 0.0012% of average net assets, and portfolio turnover was 4%.
RXL Fees and Expenses
Annual operating expenses and sales charges of RXL. Prospectus, as of March 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.75% |
| 12b-1 fee | — |
| Other expenses | 0.30% |
| Gross expense ratio | 1.05% |
| Fee waiver | −0.10% |
| Net expense ratio | 0.95% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
RXL Costs Over Time
On $10,000 invested in RXL, assuming 5% a year before costs, total costs come to $596 over 5 years, cutting the return by 1.00% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.95%) | $100 | $311 | $540 |
| Trading costs (broker commissions) | $0 | $0 | $1 |
| Lost growth on money paid in costs | $0 | $15 | $55 |
| Total costs | $100 | $327 | $596 |
| Value after costs | $10,400 | $11,249 | $12,167 |
| Impact on return, per year | 1.00% | 1.00% | 1.00% |
RXL Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending May 31, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0012%
- Total broker commissions: $861
- Bought from dealers (principal trades, not a cost): $161.3M
- Portfolio turnover (prospectus): 4%
- Securities on loan, average value: $28K
- Net income from securities lending: $744 (0.001% of average net assets)
RXL Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Susquehanna Financial Group, LLLP | $538 | 62.50% |
| BNP Paribas Securities Corp. | $323 | 37.50% |
RXL Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| J.P. Morgan Securities LLC | $135.7M | 84.11% |
| Goldman Sachs & Co. LLC | $12.6M | 7.81% |
| Bank of Montreal | $5.0M | 3.09% |
| Merrill Lynch, Pierce, Fenner & Smith Inc. | $4.6M | 2.82% |
| Jane Street Capital, LLC | $2.6M | 1.60% |
| Virtu Americas LLC | $912K | 0.57% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.